Envista Holdings (NVST) Total Non-Current Liabilities (2018 - 2026)

Envista Holdings' (NVST) quarterly Total Non-Current Liabilities came in at $5.4 billion in Q2 2026, up 1.84% year-on-year from $5.3 billion in Q2 2025, and down 1.83% quarter-over-quarter from $5.5 billion in Q4 2025.

Envista Holdings (NVST) Total Non-Current Liabilities (2018 - 2026) Analysis & Trends

Envista Holdings' Total Non-Current Liabilities history runs 9 years deep, the most recent figure standing at $5.4 billion for Q2 2026.

  • On a quarterly basis, Total Non-Current Liabilities rose 1.84% year-over-year to $5.4 billion in Q2 2026; TTM through Apr 2026 was $5.4 billion, a 1.84% increase from a year earlier, with the FY2025 full-year figure at $5.5 billion, up 5.89% from the prior year.
  • Total Non-Current Liabilities slipped to $5.4 billion in Q2 2026 per NVST's latest filing, from $5.5 billion in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $6.5 billion in Q3 2023 and bottomed at $5.2 billion in Q4 2024.
  • The 5-year median for Total Non-Current Liabilities is $6.2 billion (2022), against an average of $5.9 billion.
  • Across the five-year window, Total Non-Current Liabilities grew 6.18% in 2022 and slipped 19.37% in 2024, its largest moves.
  • Year by year, Total Non-Current Liabilities stood at $6.4 billion in 2022, then gained by 0.42% to $6.5 billion in 2023, then declined by 19.37% to $5.2 billion in 2024, then grew by 5.89% to $5.5 billion in 2025, then dropped by 1.83% to $5.4 billion in 2026.
  • Per Business Quant, the three latest NVST Total Non-Current Liabilities figures stand at $5.4 billion (Q2 2026), $5.5 billion (Q4 2025), and $5.5 billion (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn 6.48 Bn
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn 1.92 Bn
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn 48.37 Bn
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn 17.13 Bn
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn 941.16 Mn
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn 996.30 Mn
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn 4.24 Bn
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn 8.65 Bn
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn 2.06 Bn
10 Envista Holdings 4.29 Bn 3.20 Bn 390.10 Mn 5.42 Bn

Historic Data

Download Data
DateValue
Apr 3, 2026 5.42 Bn
Dec 31, 2025 5.52 Bn
Sep 26, 2025 5.47 Bn
Jun 27, 2025 5.49 Bn
Mar 28, 2025 5.32 Bn
Dec 31, 2024 5.21 Bn
Sep 27, 2024 5.36 Bn
Jun 28, 2024 5.29 Bn
Mar 29, 2024 6.42 Bn
Dec 31, 2023 6.46 Bn
Sep 29, 2023 6.53 Bn
Jun 30, 2023 6.45 Bn
Mar 31, 2023 6.42 Bn
Dec 31, 2022 6.44 Bn
Sep 30, 2022 6.19 Bn
Jul 1, 2022 6.26 Bn
Apr 1, 2022 6.28 Bn
Dec 31, 2021 6.27 Bn
Oct 1, 2021 6.24 Bn
Jul 2, 2021 6.07 Bn